Literature DB >> 25238172

Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as anti-breast cancer agents through microtubule stabilization.

B Sathish Kumar1, Amit Kumar2, Jyotsna Singh2, Mohammad Hasanain2, Arjun Singh1, Kaneez Fatima1, Dharmendra K Yadav1, Vinay Shukla2, Suaib Luqman1, Feroz Khan1, Debabrata Chanda1, Jayanta Sarkar2, Rituraj Konwar2, Anila Dwivedi2, Arvind S Negi3.   

Abstract

2-Methoxyestradiol (2ME2) is an investigational anticancer drug. In the present study, 2-alkoxyesters/acid and 2-benzyloxy analogues of estradiol have been synthesized as analogues of 2ME2. Three of the derivatives exhibited significant anticancer activity against human breast cancer cell lines. The best analogue of the series i.e. 24 showed stabilization of tubulin polymerisation process. It was substantiated by confocal microscopy and molecular docking studies where 24 occupied 'paclitaxel binding pocket' to stabilize the polymerisation process. Compound 24 significantly inhibited MDA-MB-231 cells (IC50: 7 μM) and induced arrest of cell cycle and apoptosis in MDA-MB-231 cells. In acute oral toxicity, 24 was found to be non-toxic and well tolerated in Swiss albino mice up to 1000 mg/kg dose.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acute oral toxicity; Antiestrogenicity; Breast cancer; Cell cycle; Estrogenicity; Microtubule stabilization

Mesh:

Substances:

Year:  2014        PMID: 25238172     DOI: 10.1016/j.ejmech.2014.09.033

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  14 in total

1.  Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease.

Authors:  Emanuelle Machado Marinho; João Batista de Andrade Neto; Jacilene Silva; Cecília Rocha da Silva; Bruno Coelho Cavalcanti; Emmanuel Silva Marinho; Hélio Vitoriano Nobre Júnior
Journal:  Microb Pathog       Date:  2020-06-30       Impact factor: 3.738

2.  Synthesis of Michael Adducts as Key Building Blocks for Potential Analgesic Drugs: In vitro, in vivo and in silico Explorations.

Authors:  Sajjad Ahmad; Mater H Mahnashi; Bandar A Alyami; Yahya S Alqahtani; Farhat Ullah; Muhammad Ayaz; Muhammad Tariq; Abdul Sadiq; Umer Rashid
Journal:  Drug Des Devel Ther       Date:  2021-03-23       Impact factor: 4.162

Review 3.  Patient-derived xenograft models in hepatopancreatobiliary cancer.

Authors:  Binhua Pan; Xuyong Wei; Xiao Xu
Journal:  Cancer Cell Int       Date:  2022-01-28       Impact factor: 5.722

Review 4.  New Insights Into Cancer Chronotherapies.

Authors:  Jingxuan Zhou; Jiechen Wang; Xiaozhao Zhang; Qingming Tang
Journal:  Front Pharmacol       Date:  2021-12-13       Impact factor: 5.810

5.  MST1/2 inhibitor XMU-MP-1 alleviates the injury induced by ionizing radiation in haematopoietic and intestinal system.

Authors:  Xiaoliang Zhou; Hao Wang; Deguan Li; Naling Song; Fujun Yang; Wenqing Xu
Journal:  J Cell Mol Med       Date:  2022-01-27       Impact factor: 5.310

Review 6.  A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities.

Authors:  Hossein Moutabian; Mehrsa Majdaeen; Ruhollah Ghahramani-Asl; Masoumeh Yadollahi; Esmaeil Gharepapagh; Gholamreza Ataei; Zahra Falahatpour; Hamed Bagheri; Bagher Farhood
Journal:  Cancer Cell Int       Date:  2022-04-02       Impact factor: 5.722

7.  Prediction of Potential Small Molecule-Associated MicroRNAs Using Graphlet Interaction.

Authors:  Na-Na Guan; Ya-Zhou Sun; Zhong Ming; Jian-Qiang Li; Xing Chen
Journal:  Front Pharmacol       Date:  2018-10-15       Impact factor: 5.810

8.  Evaluation of anti-tumour properties of two depsidones - Unguinol and Aspergillusidone D - in triple-negative MDA-MB-231 breast tumour cells.

Authors:  A Zwartsen; S Chottanapund; P Kittakoop; P Navasumrit; M Ruchirawat; M B M Van Duursen; M Van den Berg
Journal:  Toxicol Rep       Date:  2019-10-20

9.  Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma.

Authors:  Weiwei Liu; Lu Zheng; Rongguiyi Zhang; Ping Hou; Jiakun Wang; Linquan Wu; Jing Li
Journal:  Mol Cancer       Date:  2022-03-11       Impact factor: 27.401

10.  LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis.

Authors:  Peng Li; Yu Zeng; Yudan Chen; Peng Huang; Xinchun Chen; Weidong Zheng
Journal:  Cancer Cell Int       Date:  2022-03-12       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.